Home

Premier préjudice chaussettes jean paul clozel actelion nulle part Isoler Submerger

Actelion wins FDA approval for hypertension drug - San Francisco Business  Times
Actelion wins FDA approval for hypertension drug - San Francisco Business Times

Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New  Biotech Firm - WSJ
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ

38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images

European pharma: CEO talent is the new measure of company calibre
European pharma: CEO talent is the new measure of company calibre

Was plant das Ehepaar Clozel? | NZZ
Was plant das Ehepaar Clozel? | NZZ

Who wants to be a billionaire? Not Actelion's founder and CEO, if it means  selling out | Fierce Pharma
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma

Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not  acquisition - CEOWORLD magazine
Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine

Actelion Story - Profile, History, Founder, CEO | Famous Pharmaceutical  Companies | SuccessStory
Actelion Story - Profile, History, Founder, CEO | Famous Pharmaceutical Companies | SuccessStory

Medical couple and butcher's boy win big from Actelion sale | Reuters
Medical couple and butcher's boy win big from Actelion sale | Reuters

Actelion never made offer for ZS Pharma: CEO
Actelion never made offer for ZS Pharma: CEO

Profile: Jean-Paul Clozel | Nature Biotechnology
Profile: Jean-Paul Clozel | Nature Biotechnology

Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock  rise and talk of partnering up for pivotal trial | Fierce Biotech
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech

Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels  (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference  at Actelion headquarters in Allschwil, Switzerland January 26, 2017.  REUTERS/Arnd Wiegmann
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann

J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal - Bloomberg
J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal - Bloomberg

Jean-Paul Clozel, CEO Actelion - YouTube
Jean-Paul Clozel, CEO Actelion - YouTube

Actelion's Jean-Paul Clozel aims to keep group's independence | Financial  Times
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times

Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS

Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm -  TheStreet
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet

Startup Guide on Twitter: "Jean-Paul and Martine Clozel are experienced  founders and leading figures in the Basel Area. After Actelion, the first  company they cofounded, was acquired by Johnson & Johnson, they
Startup Guide on Twitter: "Jean-Paul and Martine Clozel are experienced founders and leading figures in the Basel Area. After Actelion, the first company they cofounded, was acquired by Johnson & Johnson, they

From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel &  Martine Clozel
From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel & Martine Clozel

World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr

Actelion-Gründer ausgezeichnet – Berührende Würdigung eines Erfolgs-Teams |  Basler Zeitung
Actelion-Gründer ausgezeichnet – Berührende Würdigung eines Erfolgs-Teams | Basler Zeitung

PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)

Actelion Could Boost Takeover Price for Johnson & Johnson
Actelion Could Boost Takeover Price for Johnson & Johnson